The global chronic heart failure therapeutics market is witnessing a period of marked growth. This rise can be credited to the rising prevalence of chronic heart failure globally, coupled with developments in treatment approaches. The market is characterized by a diverse range of medications, targeting different aspects of the disease. Key players